Hypothesis

7 Matching Annotations

Last 7 days
www.sciencedirect.com www.sciencedirect.com

Targeting RPL4 improves the therapeutic efficacy of PD-L1 blockade in liver fibrosis

1
1. scibot 24 Sep 2026
  
  in Public
  
  RRID:AB_2801079
  
  DOI: 10.1016/j.xcrm.2026.103056
  
  Resource: (BioLegend Cat# 396410, RRID:AB_2801079)
  
  Curator: @scibot
  
  SciCrunch record: RRID:AB_2801079
  
  What is this?
  
  RRID:AB_2801079
Visit annotations in context

Tags

RRID:AB_2801079

Annotators

scibot

URL

sciencedirect.com/science/article/pii/S2666379126004738
Jul 2026
www.sciencedirect.com www.sciencedirect.com

Extracellular ATP-P2RY2 signaling drives intratumoral prostaglandin E2 accumulation and adaptive resistance to immunotherapy in solid tumors

1
1. scibot 05 Jul 2026
  
  in Public
  
  RRID:AB_2801079
  
  DOI: 10.1016/j.immuni.2026.06.006
  
  Resource: (BioLegend Cat# 396410, RRID:AB_2801079)
  
  Curator: @scibot
  
  SciCrunch record: RRID:AB_2801079
  
  What is this?
  
  RRID:AB_2801079
Visit annotations in context

Tags

RRID:AB_2801079

Annotators

scibot

URL

sciencedirect.com/science/article/pii/S1074761326002578
Mar 2026
pmc.ncbi.nlm.nih.gov pmc.ncbi.nlm.nih.gov

Sym024 interacts with a unique epitope on the CD73 homodimer, favoring effective bivalent binding to improve anti-PD1 therapy

1
1. scibot 04 Mar 2026
  
  in Public
  
  RRID:AB_2801079
  
  DOI: 10.1158/1078-0432.CCR-25-2406
  
  Resource: (BioLegend Cat# 396410, RRID:AB_2801079)
  
  Curator: @evieth
  
  SciCrunch record: RRID:AB_2801079
  
  What is this?
  
  RRID:AB_2801079
Visit annotations in context

Tags

RRID:AB_2801079

Annotators

scibot

URL

pmc.ncbi.nlm.nih.gov/articles/PMC12950896/
Nov 2024
www.sciencedirect.com www.sciencedirect.com

Multimodal targeting chimeras enable integrated immunotherapy leveraging tumor-immune microenvironment

1
1. scibot 14 Nov 2024
  
  in Public
  
  RRID:AB_2801079
  
  DOI: 10.1016/j.cell.2024.10.016
  
  Resource: (BioLegend Cat# 396410, RRID:AB_2801079)
  
  Curator: @scibot
  
  SciCrunch record: RRID:AB_2801079
  
  What is this?
  
  RRID:AB_2801079
Visit annotations in context

Tags

RRID:AB_2801079

Annotators

scibot

URL

sciencedirect.com/science/article/pii/S009286742401198X
Feb 2024
www.ncbi.nlm.nih.gov www.ncbi.nlm.nih.gov

UB-612 pan-SARS-CoV-2 T cell immunity-promoting vaccine protects against COVID-19 moderate-severe disease

1
1. scibot 08 Feb 2024
  
  in Public
  
  RRID:AB_2801079
  
  DOI: 10.1016/j.isci.2024.108887
  
  Resource: (BioLegend Cat# 396410, RRID:AB_2801079)
  
  Curator: @scibot
  
  SciCrunch record: RRID:AB_2801079
  
  What is this?
  
  RRID:AB_2801079
Visit annotations in context

Tags

RRID:AB_2801079

Annotators

scibot

URL

ncbi.nlm.nih.gov/pmc/articles/PMC10839960/
Nov 2022
www.sciencedirect.com www.sciencedirect.com

Chronic type I interferon signaling promotes lipid-peroxidation-driven terminal CD8+ T cell exhaustion and curtails anti-PD-1 efficacy

1
1. scibot 16 Nov 2022
  
  in Public
  
  RRID:AB_2801079
  
  DOI: 10.1016/j.celrep.2022.111647
  
  Resource: (BioLegend Cat# 396410, RRID:AB_2801079)
  
  Curator: @scibot
  
  SciCrunch record: RRID:AB_2801079
  
  What is this?
  
  RRID:AB_2801079
Visit annotations in context

Tags

RRID:AB_2801079

Annotators

scibot

URL

sciencedirect.com/science/article/pii/S2211124722015182
Jul 2022
www.sciencedirect.com www.sciencedirect.com

Tissue-resident memory and circulating T cells are early responders to pre-surgical cancer immunotherapy

1
1. scibot 08 Jul 2022
  
  in Public
  
  RRID:AB_2801079
  
  DOI: 10.1016/j.cell.2022.06.018
  
  Resource: (BioLegend Cat# 396410, RRID:AB_2801079)
  
  Curator: @scibot
  
  SciCrunch record: RRID:AB_2801079
  
  What is this?
  
  RRID:AB_2801079
Visit annotations in context

Tags

RRID:AB_2801079

Annotators

scibot

URL

sciencedirect.com/science/article/pii/S0092867422007231